Treatment of cardiovascular disorders of the newborn.
D001238:Asphyxia Neonatorum / Q000150:complications; D001803:Blood Transfusion; D002318:Cardiovascular Diseases / Q000209:etiology / Q000628:therapy*; D002319:Cardiovascular System / Q000196:embryology; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004899:Erythroblastosis, Fetal / Q000150:complications; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D006336:Heart Massage; D006801:Humans; D006819:Hyaline Membrane Disease / Q000628:therapy; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy*; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007328:Insulin / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D011015:Pneumonia, Aspiration / Q000150:complications; D011247:Pregnancy; D011660:Pulmonary Heart Disease / Q000209:etiology; D012771:Shock, Hemorrhagic / Q000628:therapy; D006475:Vitamin K Deficiency Bleeding / Q000628:therapy
D004071:Digitalis Glycosides; D007328:Insulin; D005947:Glucose